RU95115500A - MEANS FOR PREVENTIVE, SUPPORTING AND RESTORATIVE THERAPIES FOR DEVELOPING DURING AGING AND / OR UNDER INFLUENCE OF PATHOGENIC FACTORS OF PATHOLOGIES RELATED TO DYSTROPHIC AND ORGENERANIC TENGENISMAN - Google Patents

MEANS FOR PREVENTIVE, SUPPORTING AND RESTORATIVE THERAPIES FOR DEVELOPING DURING AGING AND / OR UNDER INFLUENCE OF PATHOGENIC FACTORS OF PATHOLOGIES RELATED TO DYSTROPHIC AND ORGENERANIC TENGENISMAN

Info

Publication number
RU95115500A
RU95115500A RU95115500/14A RU95115500A RU95115500A RU 95115500 A RU95115500 A RU 95115500A RU 95115500/14 A RU95115500/14 A RU 95115500/14A RU 95115500 A RU95115500 A RU 95115500A RU 95115500 A RU95115500 A RU 95115500A
Authority
RU
Russia
Prior art keywords
dystrophic
tengenisman
orgeneranic
preventive
supporting
Prior art date
Application number
RU95115500/14A
Other languages
Russian (ru)
Other versions
RU2083210C1 (en
Inventor
Э.М. Пеганов
С.Л. Булдакова
Л.М. Шаповалова
Original Assignee
Николаева И.С.
Э.М. Пеганов
Filing date
Publication date
Application filed by Николаева И.С., Э.М. Пеганов filed Critical Николаева И.С.
Priority to RU95115500A priority Critical patent/RU2083210C1/en
Priority claimed from RU95115500A external-priority patent/RU2083210C1/en
Priority to PCT/RU1996/000255 priority patent/WO1997009991A1/en
Priority to EP96931314A priority patent/EP0893123A4/en
Application granted granted Critical
Publication of RU2083210C1 publication Critical patent/RU2083210C1/en
Publication of RU95115500A publication Critical patent/RU95115500A/en

Links

Claims (1)

Применение оксида дейтерия в качестве средства для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическими и дегенеративными изменениями органов и тканей.The use of deuterium oxide as a means for prophylactic, supportive and restorative therapy of pathologies developing during aging and / or under the influence of pathogenic factors associated with dystrophic and degenerative changes in organs and tissues.
RU95115500A 1995-09-13 1995-09-13 Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations RU2083210C1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU95115500A RU2083210C1 (en) 1995-09-13 1995-09-13 Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations
PCT/RU1996/000255 WO1997009991A1 (en) 1995-09-13 1996-09-10 Agent for use in the prevention and treatment of disorders associated with various types of ageing
EP96931314A EP0893123A4 (en) 1995-09-13 1996-09-10 Agent for use in the prevention and treatment of disorders associated with various types of ageing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95115500A RU2083210C1 (en) 1995-09-13 1995-09-13 Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations

Publications (2)

Publication Number Publication Date
RU2083210C1 RU2083210C1 (en) 1997-07-10
RU95115500A true RU95115500A (en) 1997-09-10

Family

ID=20171820

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95115500A RU2083210C1 (en) 1995-09-13 1995-09-13 Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations

Country Status (3)

Country Link
EP (1) EP0893123A4 (en)
RU (1) RU2083210C1 (en)
WO (1) WO1997009991A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031397A1 (en) * 2007-07-05 2009-01-08 D2O Bioscience Group Ltd. Use of deuterium oxide for the treatment of virus-based diseases of the skin
ES2459198T3 (en) * 2008-04-20 2014-05-08 D2 Bioscience Group Ltd Use of deuterium oxide as an elastase inhibitor
DE102009003942A1 (en) 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Use of deuterium oxide for the treatment of virus-based diseases of the eye
DE102009003992A1 (en) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
DE69434598T3 (en) * 1993-07-29 2010-07-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Use of paclitaxel and its derivatives for the manufacture of a medicament for the treatment of restenosis
DE4427690A1 (en) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Pharmaceutical composition containing deuterium as a cytostatic or tumor therapeutic
GB2293100A (en) * 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide

Similar Documents

Publication Publication Date Title
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
NO986052L (en) Anticonvulsant sulphamate derivatives for use in the treatment of obesity
AU535300B2 (en) Creping tissue
CA2126083A1 (en) Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis
GB2301366A (en) Antibodies against E-selectin
EP0624344A3 (en) Diathermy handpiece with endoscopic probe.
ES482097A1 (en) Novel acyl-derivatives of carnitine and process for their preparation
ES2196082T3 (en) ANALAGOS OF THE QUERATINOCIT GROWTH FACTOR.
CA2164951A1 (en) Lipoxin compounds
ES2193233T3 (en) USE OF AMIODIPINE, A SALT OF THE SAME OR PHELODIPINE IN COMBINATION WITH AN ACE INHIBITOR IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NON-ISCHEMICAL CONJUNCTIVE HEART FAILURE.
RU95115500A (en) MEANS FOR PREVENTIVE, SUPPORTING AND RESTORATIVE THERAPIES FOR DEVELOPING DURING AGING AND / OR UNDER INFLUENCE OF PATHOGENIC FACTORS OF PATHOLOGIES RELATED TO DYSTROPHIC AND ORGENERANIC TENGENISMAN
DK317285D0 (en) PHARMACOLOGICAL EFFECTS (PYRROL-1-YL) -PHENYL-DIHYDROPYRIDAZINONES AND PROCEDURES FOR PREPARING IT
FI965094A0 (en) 2,4,6-Triiodo-5-substituted aminoisophthalate esters useful as contrast agents in medical diagnostic imaging
AU1086888A (en) Primary biliary cirrhosis autoantigen
NO892408L (en) PROCEDURE FOR AA HOME VOLTAGE CORROSION PREPARATION IN AUSTENITIAN ALLOYS.
UA42797C2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives and isoindole derivatives for preparation thereof
DE3268716D1 (en) Peptides and process for their preparation
NO960347L (en) Use of benzydamide in the treatment of pathological conditions caused by TNF
TR199501530A1 (en) Kit for use in the therapeutic cycle in the treatment of osteoporosis.
CA2214675A1 (en) Methods and compositions for sedating, anaesthetising and euthanising aquatic organisms
DK0726942T3 (en) Foam cells monoclonal antibodies and their pharmaceutical and diagnostic use
IT1225800B (en) DOUBLE POLARIZER, FOR THE OBSERVATION OF CINESCOPES IN GENERAL
ITPD950124A0 (en) PROCEDURE FOR THE STERILIZATION OF CORK STOPS
RU95117476A (en) NATURAL SKIN OVER
IT8322170A0 (en) COMPOUNDS SUITABLE FOR THE THERAPEUTIC TREATMENT OF BILIARY ALTERATIONS, PARTICULARLY OF LITHOGEN BILE AND CHOLESTEROL STONES AND PHARMACEUTICAL COMPOSITIONS THEY CONTAIN.